| 15 | Molecular effects of docosahexaenoic acid on carcinogenesis and tumor progression processes
Rescigno T., Capasso A., Tecce Mm. |
| 100 | Mitochondrial network organization in cisplatin resistant cells
Vianello C., Catanzaro D., Ragazzi E., Caparrotta L., Montopoli M. |
| 117 | Pharmacological blockade of A2B adenosine receptor reduces tumor angiogenesis and immunosuppression in a mouse model of melanoma
Sorrentino C., Loffredo MT., Porta A., Pinto A., Morello S. |
| 149 | Effect of NO and H2S releasing doxorubicins on an in vitro model of colon cancer with MDR phenotype
Cinci L., Chegaev K., Riganti C., Bigagli E., Luceri C. |
| 180 | Involvement of the L-cysteine/CSE/H2S pathway in human melanoma progression
Armogida C., Panza E., De Cicco P., Ercolano G., Botti G., Papapetropoulos A., Cirino G., Ianaro A. |
| 193 | H2S-donors induce apoptosis of human melanoma cells
Ercolano G., Panza E., Armogida C., De Cicco P., Sessa G., Pirozzi G., Papapetropoulos A., Cirino G., Ianaro A. |
| 202 | AOX-3 effects, a novel 5-lipoxygenase inhibitor, in breast cancer cells
Ferraiolo FAV., Ciuffreda LP., Filosa R., Rivellino A., Berrino L. |
| 265 | In vitro and in vivo efficacy of an orally bioavailable antagonist of Eph-ephrin system in tumor angiogenesis and growth
Giorgio C., Castelli R., Hassan-Mohamed I., Incerti M., Vacondio F., Bertoni S., Festuccia C., Pala D., Lodola A., Barocelli E., Tognolini M. |
| 284 | The non-receptor tyrosine kinase Fes promotes the growth and the metastatic progression of neuroblastoma tumor
Gnemmi I., Riva B., Condorelli F., Canonico PL. |
| 300 | NF-κB is a potential pharmacological target in triple negative breast cancers
Labbozzetta M., Poma P., Vivona N., D'Alessandro N., Notarbartolo M. |
| 306 | The synergistic activity of irinotecan and sunitinib in anaplastic thyroid cancer: a new combined treatment approach
Di Desidero T., Orlandi P., Fioravanti A., Danesi R., Bocci G. |
| 307 | Preclinical metronomic topotecan and pazopanib combination in primary or late stage metastatic triple-negative breast cancer
Di Desidero T., Xu P., Man S., Kerbel RS., Bocci G. |
| 308 | Celecoxib Targets CML Blasts Proliferation in a COX-2 independent manner
Riva B., De Dominici M., Gnemmi I., Salomoni P., Canonico PL., Calabretta B., Condorelli F. |
| 320 | The oscillatory expression of ERα as a new drug target for resensitizing hormone-refractory breast cancer
Dell'Omo G., Vantaggiato C., Villa A., Maggi A., Ciana P. |
| 328 | Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a new tumoural cytokine released from melanoma
Torretta S., Travelli C., Amoruso A., Orsomando G., Canonico PL., Genazzani AA., Grolla AA. |
| 363 | Antiviral activity of different 1,4-dimethyl-9H-carbazoles
Caporale A., Iacopetta D., Sinicropi MS., Caruso A., Mordocco R., Autore G., Saturnino C. |
| 373 | In vivo imaging of ER activation reveals an inflammatory switch as a common early pro-carcinogenesis step in breast tumorigenesis
Vantaggiato C., Dell'Omo G., Gazzotti M., Capris I., Greco V., Maggi A., Ciana P. |
| 376 | Effects of CYP17A1 enzyme inhibition with Abiraterone Acetate in NCl-H295R, a Human Adrenocortical Cancer-Derived Cell Line
Fragni M., Fiorentini C., Vezzoli S., Bonini SA., Missale C., Tiberio GAM., De Ferrari F., Memo M., Berruti A., Sigala S. |
| 385 | Atmospheric non-equilibrium plasma promotes cell death and cell-cycle arrest in a lymphoma cell line
Catanzaro E., Turrini E., De Gianni E., Gherardi M., Laurita R., Stancampiano A., Colombo V., Fimognari C. |
| 409 | Dihydroxyphenylethanol, a product from olive oil, reduces colon cancer growth by enhancing EGFR degradation
Terzuoli E., Giachetti A., Bazzani L., Ziche M., Donnini S. |
| 416 | Amiloride in the management of the secondary mineralocorticoid excess syndrome induced by Abiraterone Acetate in Castration-Resistant Prostate Cancer (CRPC): in vivo and in vitro evidence
Bedussi F., Galli D., Fragni M., Vezzoli S., Valcamonico F., Ferrari L., Dalla Volta A., De Ferrari F., Memo M., Berruti A., Sigala S. |
| 442 | EGF contributes to the pathogenesis of lymphangioleiomyomatosis by affecting ERK pathway
Ancona S., Prinelli A., Chiaramonte E., Di Giulio AN., Gorio A., Pesenti C., Baisi A., Sirchia SM., Lesma E. |
| 443 | Molecular profile of tumor response to everolimus in different breast cancer cell lines
Citi V., Del Re M., Martelli A., Palombi M., Testai L., Calderone V., Danesi R., Breschi MC. |
| 471 | Evaluation of inhibitory activity and selectivity of novel sulfasalazine analogues towards human glutathione transferases
Calderan L., Di Paolo V., Castellano S., Balzano AL., Saggioro D., Ciancetta A., Deganutti G., Milite C., Sbardella G., Moro S., Quintieri L. |
| 476 | Effects of CB83 a new resorcinol-anandamide “hybrid” derivative on HT29 colon cancer cells
Micheli L., Cerretani D., Fiaschi AI., Martino EC., Brizzi A., Pannini S., Passarello F., Lorè F., Menchiari A., Montefrancesco G., Giorgi G. |
| 478 | Vinorelbine metronomic chemotherapy for advanced tumor patients: observational study.
Bertolaso L., Bononi A., Modena Y., Menon D., Barile C., Crepaldi G., Pasini F., Giusti P., Caruso D., Guesella M., Pezzolo E., Gaspardo A. |
| 448 | Effects of tyrosol and hydroxytyrosol in adenocarcinoma lung cancer cells exposed to hydrogen peroxide
Gallelli L., Falcone D., Stefanelli R., Pelaia G., Maselli R., Savino R., Cione E., Caroleo M., De Sarro G. |
| 501 | Dual Actions of the Voltage-Dependent Potassium Channel Modulators on Cell Proliferation in SH-SY5Y Neuroblastoma Cells
Curci A., Mele A., Maqoud F., Camerino GM., Zizzo N., Tricarico D. |
| 514 | Involvement of TRPM8 in colorectal cancer cell viability
Finizio S., Pagano E., Romano B., Capasso R., Orlando P., Izzo AA., Borrelli F. |
| 548 | Characterization of the role of the endocannabinoid system in human melanoma cells
Carpi S., Montagnani V., Stecca B., Polini B., Breschi MC., Nieri P., Fogli S. |
| 570 | Amphiphilic PLGA-poloxamer nanoparticles for the controlled release of silibinin
Serri C., Giarra S., Mita DG., Saija A., De Rosa G., Mayol L., Biondi M. |
| 595 | Cytotoxic effect of Camptothecin nanosponges on anaplastic thyroid cancer cells in vitro and on orthotopic xenograft tumors in vivo
Ferrara B., Gigliotti LC., Occhipinti S., Boggio E., Barrera G., Pizzimenti S., Giovarelli M., Fantozzi R., Chiocchetti A., Trotta F., Dianzani U., Cavalli R., Dianzani C. |
| 634 | The flavonoid fraction of mandarin juice acts as anti-proliferative and anti-migratory agent toward anaplastic thyroid carcinoma cells
Cirmi S., Celano M., Maggisano V., De Rose RF., Bulotta S., Maiuolo J., Lombardo GE., Ferlazzo N., Russo D., Navarra M. |
| 632 | In vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori
Ferlazzo N., Filocamo A., Bisignano C., Cirmi S., Mandalari G., Navarra M. |
| 635 | Growth inhibition, cell-cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells by bergamot juice
Cirmi S., Ferlazzo N., Lombardo GE., Calapai G., Navarra M. |
| 674 | Hep G2 behaviour in 3D electrospun scaffolds as in vitro cancer inhibitor model
Fasolino I., Guarino V., Cirillo V., Marrese M., Vallifuoco M., Tamma ML., Bracco A., Calise F., Ambrosio L. |
| 636 | In vitro antimicrobial activity of a white grape juice (Vitis vinifera) extract
Cirmi S., Bisignano C., Filocamo A., Mandalari G., Lombardo GE., Ferlazzo N., Navarra M. |
| 610 | SR141716 exerts antitumor effect in colorectal cancer through WNT/β-Catenin-mediated pathway
Proto MC., Fiore D., Pagano Zottola AC., Pisanti S., Ciaglia E., Picardi P., Malfitano AM., Laezza C., Bifulco M., Gazzerro P. |
| 604 | A role for DHA and aspirin-acetylated COX-2 metabolites on cancer related angiogenesis
Vara-Messler M., Trenti A., Buccellati C., Sala A., Pasqualini ME., Trevisi L., Bolego C. |
| 687 | Bevacizumab and cetuximab in metastatic colorectal cancer in women and men: a retrospective multicentric study in Toscana
Donnini S., Ettorre A., Paoletti D., Francini G., Gasperini G., Crispino S., Petrucci G., Lena F., Bengala C., Cecchi M., Antonuzzo L., Di Costanzo F., Giorgi S., Ziche M. |
| 684 | EGFR nuclear translocation in human lung cancer cells: role of Prostaglandin E2
Bazzani L., Finetti F., Donnini S., Ziche M. |
| 736 | “The dark side of Nrf2” A metabolomic pilot study about the role of the transcription factor NRF2 in glycolysis, in KrasG12D-driven non-small cell lung cancer mouse model
Consolini N., Singh A., Lane A., Higashi R., Fan T., Biswal S., Hrelia P. |
